Emergence of resistance of vancomycin-resistant Enterococcus faecium in a thermal injury patient treated with quinupristin-dalfopristin and cultured epithelial autografts for wound closure

Burns

Volumn 28, Issue 7, 2002, Pages 696-698

  Rose, Christina M ^a   Reilly, Kathleen J ^b   Haith Jr , Linwood R ^b   Patton, Mary L ^b   Guilday, Robert J ^b   Cawley, Michael J ^c   Ackerman, Bruce H ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CROZER CHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Enterococcal infections in thermal injury patients; Enterococcus faecium bacteremia in critical care; Quinupristin dalfopristin treatment failure; Quinupristin dalfopristin resistant Enterococcus faecium

Indexed keywords

CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BODY SURFACE; BURN; CASE REPORT; DISEASE COURSE; DRUG EFFECT; ENTEROCOCCUS FAECIUM; FEVER; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; MALE; SKIN AUTOGRAFT; THERMAL INJURY; TREATMENT OUTCOME; WOUND CLOSURE;

ADULT; BURNS; CHLORAMPHENICOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAFT SURVIVAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; SKIN TRANSPLANTATION; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 0036844218     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(02)00105-5     Document Type: Article

References (15)

1. Linden P.K., Pasculle A.W., Manex R., Kramer D.J., Fung J.J., Pinna A.Det al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin. Infect. Dis. 22:1996;663-670.
2. Linden P.K., Pasculle A.W., Manez R., Kramer D.J., Fung J.J., Pinna A.Det al. Vancomycin resistance and mortality associated with enterococcal bacteremia. Clin. Infect. Dis. 24(3):1997;530-531.
3. Edmond M.B., Ober J.F., Dawson J.D., Weinbaum D.L., Wenzel R.P. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis. 23(12):1996;1234-1239.
4. Norris A.H., Reilly J.P., Edelstein P.H., Brennan P.J., Schuster M.G. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin. Infect. Dis. 20:1995;1137-1144.
5. Lautenbach D., Schuster M.G., Bilker W.B. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant enterococcus. Clin. Infect. Dis. 27:1998;1259-1265.
6. Lautenbach E., Bilker W.B., Brennan P.J. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect. Control Hosp. Epidemiol. 20(5):1999;318-323.
7. Heggers J.P., McCoy L., Reisner B., Smith M., Edgar P., Ramirez R.J. Alternate antimicrobial therapy for vancomycin-resistant enterococci burn wound infections. J. Burn Care Rehabil. 19(5):1998;399-403.
8. Landman D., Quale J.M. Management of infections due to resistant enterococci: a review of therapeutic options. J. Antimicrob. Chemother. 40:1997;161-170.
9. Griswold M.W., Lomaestro B.M., Briceland L.L. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination. Am. J. Health Syst. Pharm. 53:1996;2045-2053.
10. Caron F., Gold H.S., Wennersten C.B., Farris M.G., Moellering R.C. Jr., Eliopoulos G.M. Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 41(12):1997;2749-2753.
11. Matsumura S.O., Louie L., Louie M., Simor A.E. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents. Antimicrob. Agents Chemother. 43(11):1999;2776-2779.
12. Moellering R.C. Jr. Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections. J. Antimicrob. Chemother. 44(Topic A):1999;25-30.
13. Soltani M., Deighton D., Philpott-Howard J., Woodford N. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in western Europe. Antimicrob. Agents Chemother. 44(2):2000;433-436.
14. McCarthy K.M., van Nierop W., Duse A., von Gottberg A., Kassel M., Perovic Oet al. Control of an outbreak of vancomycin-resistant Enterococcus faecium in an oncology ward in South Africa: effective use of limited resources. J. Hosp. Infect. 44:2000;294-300.
15. Bozdogan B., Leclercq R. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob. Agents Chemother. 43(11):1999;2720-2725.